K2 Study: A Groundbreaking Heart Development

Overview


NattoPharma-RS-Food-2015-K2-Study-A-Groundbreaking-Heart-Development.png

A recognized risk factor for poor cardiovascular health, arterial stiffening is caused by several mechanisms, among them elastin breakdown and microcalcification; unfortunate results of aging. But arterial calcification is actually an actively regulated process. Yet Matrix Gla Protein (MGP), the most potent vascular calcification inhibitor, can only fulfill its protecting role if the body has adequate Vitamin K2 to activate it.

Previous data suggest a strong link between Vitamin K2 intake and cardiovascular health, but a newly published MenaQ7® study confirms the nutrient’s essential role.

This content is provided by NattoPharma – Gnosis by Lesaffre, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Related Resources

Children’s Bones Need Vitamins K2 & D3

Children’s Bones Need Vitamins K2 & D3

Content provided by NattoPharma – Gnosis by Lesaffre

Infographic

Childhood is a crucial period for developing healthy bone mass. However, research shows children have 8-10x higher levels of inactive osteocalcin, which means they are not optimally building the bone mass they require during this period.

Vit K2 Deficiency: Impeding Optimal Health For All

Vit K2 Deficiency: Impeding Optimal Health For All

Content provided by NattoPharma – Gnosis by Lesaffre

White Paper

NattoPharma created the Vitamin K2 category, driving all research demonstrating bone- and heart-health benefits of MenaQ7® Vitamin K2 as MK-7. That research has the medical community conducting its own trials exploring K2 as a potential therapy.

Supplier Info Centre

NattoPharma-Gnosis-by-Lesaffre.png

For more product information visit NattoPharma – Gnosis by Lesaffre.